Kedrion Biopharma’s Post

Trying to balance life-changing gene therapies and their steep costs? Watch this recording of our latest SHRM webinar from Aetna, a CVS Health Company for insights on the benefits and financial risks of these breakthrough therapies and their impact on the bottom line. #CECredit #SHRM #TeamCVS

Trying to balance life-changing gene therapies and their steep costs? Watch this recording of our latest SHRM webinar from Aetna, a CVS Health Company for insights on the benefits and financial risks of these breakthrough therapies and their impact on the bottom line. #CECredit #SHRM #TeamCVS

📅 October 15th - Associate Partner and Gene Therapy Biosafety Officer Katie George brings insight to ABSA International's annual conference. Read more below.   This advanced course assesses risks in research scenarios, covering the entire research process from discovery to clinical trials. It focuses on evaluating exposure likelihood, consequences severity, and various hazards. Participants need a solid understanding of microorganisms, rDNA principles, and biosafety's role in risk assessment. Interactive discussions and diverse risk perspectives are essential.   #Biosafety #BiosafetyNE2023 #ABSA

📅 October 15th - Associate Partner and Gene Therapy Biosafety Officer Katie George brings insight to ABSA International's annual conference. Read more below.   This advanced course assesses risks in research scenarios, covering the entire research process from discovery to clinical trials. It focuses on evaluating exposure likelihood, consequences severity, and various hazards. Participants need a solid understanding of microorganisms, rDNA principles, and biosafety's role in risk assessment. Interactive discussions and diverse risk perspectives are essential.   #Biosafety #BiosafetyNE2023

Developments in #GeneTherapies are changing the landscape of healthcare, it’s important for employers to understand their impact and opportunities these advancements may bring. Check out the latest installment in our 2024 Future Forecast video series to learn more about gene therapies: https://bit.ly/3OYHo2R #FutureForecast #SunLifeUS

🔬🌐 The European Medicines Agency endorses WFH's Gene Therapy Registry! 🌟 This initiative, in collaboration with esteemed partners, is a game-changer for the Hemophilia community. 📊 The GTR's global reach is a beacon of hope, consolidating invaluable data on Hemophilia gene therapy patients worldwide. This approach not only eliminates redundancy but also promises to uncover rare safety events and elevate the overall quality of care. 💪 The primary goal of long-term safety assessment is paramount, shedding light on known and unforeseen issues. Moreover, the GTR's emphasis on efficacy and durability ensures a holistic view of Hemophilia gene therapy's impact. 🌈 It's heartening to see the commitment to patient-centric care, with programs to empower both #healthcare centers and #patients in data management. Privacy compliance is a top priority, reassuring all stakeholders. 🤝 The collaborative governance structure, complete with a Patient Advisory Group, sets a gold standard for transparent, patient-driven research. 🧬 As we embrace the future of Hemophilia care, the GTR promises to be a vital tool in shaping regulatory decisions, health technology assessments, and clinical practice #guidelines. 🚀 Looking forward to witnessing the transformative impact of the WFH GTR and its role in advancing gene therapies for Hemophilia. #Hemophilia #GeneTherapy #PatientCare #DataForChange #HealthcareInnovation https://lnkd.in/ddGJHpcg

Useful article summarising the challenges of using viral vectors in the delivery of gene therapies in Nature Portfolio. It highlights some of the current alternatives, but many of those have their own challenges too. We’re developing a novel silica-based nanoparticle, Nuvec, that overcomes many of the drawbacks of the existing options. To find out more, see: https://lnkd.in/eVaGg3QU   #genetherapies #viralvectors #AAV 

Our latest issue brief delves into the transformative potential of cell and gene therapies. Discover why evidence-based assessments are key to patient access and health system sustainability. Download now: https://ow.ly/JPPP50PX91s

The cold, hard truth: current cryogenic containers for cell and gene therapies face a collection of challenges. RegMedNet and BioLife Solutions, Inc. present this #InFocus, which explores these challenges and how they can be addressed >>> https://bit.ly/3vhSdWs

Discover all the essentials you need for successful gene therapy adenovirus development with our new fact sheet. We'll provide you with an in-depth look at applications, virus properties, expression systems, biosafety, and workflow - everything you need to inspire confidence and move forward. Get the facts! https://lnkd.in/dHAJgJKF #AAV #viralvectors #genetherapy #cellandgenetherapy